Hideki Sugimoto

Hideki Sugimoto is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antifungal compounds. With a total of 4 patents to his name, Sugimoto's work has had a meaningful impact on medical science.

Latest Patents

Among his latest innovations are two patents related to polyene macrolide derivatives. These patents focus on Amphotericin B derivatives, where each symbol is defined in the description. The compounds developed by Sugimoto feature a 16th position (X) that includes a urea structure, cyclic structure, hydroxyalkyl, or substituted monoalkylcarbamoyl. These compounds exhibit antifungal activity, showcasing Sugimoto's commitment to addressing critical health challenges.

Career Highlights

Sugimoto is currently associated with Shionogi & Company Limited, a prominent pharmaceutical company. His work at Shionogi has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical innovations.

Collaborations

Some of his notable coworkers include Kenji Yamawaki and Keisuke Miyazaki. Their collaborative efforts have likely played a role in advancing the research and development of new pharmaceutical products.

Conclusion

In summary, Hideki Sugimoto is a distinguished inventor whose work in developing antifungal compounds has made a significant impact in the pharmaceutical industry. His innovative spirit and dedication to research continue to inspire advancements in medical science.

Profile summary based on public USPTO records.